Enjoy complimentary customisation on priority with our Enterprise License!
The global stem cell banking market size is estimated to grow by USD 8.23 billion at a CAGR of 11.65% between 2023 and 2027. The market growth is fueled by the escalating demand for personalized medicines, coupled with advancements in regenerative medicine. Personalized banking applications facilitate tailored treatments, aligning with individual patient characteristics and preferences. Stem cell-based research, especially in hematopoietic stem cell transplantations, holds promise for addressing neurodegenerative and cardiovascular conditions. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells, both used and unused, for clinical applications.
Cryogenically freezing enables long-term preservation of stem cells for future therapies. Progress in regenerative medicine, including IPS cells, offers hope for conditions previously deemed untreatable. Despite initial costs, market research and growth analysis project a promising market forecast, emphasizing the importance of continued innovation and investment in personalized healthcare solutions..
For More Highlights About this Report, Download Free Sample in a Minute
The market share growth by the adult stem cells segment will be significant during the forecast period. Adult stem-cells are found in developed tissues such as the heart, brain, and kidney, where they mature and repair damaged tissues through cell division. They are abundant in infants, children, and adults. The adult stem-cell banking segment leads the market owing to the easy availability of these cells within the human body.
Get a glance at the market contribution of various segments Download the PDF Sample
The adult stem cells segment was valued at USD 4.08 billion in 2018. Furthermore, HLA typing is used to match patients and donors before bone marrow or blood transplants. Moreover, it is important during adult stem-cell transplantation, as the donor cells can adversely affect the recipient's immune system, leading to autoimmune disorders owing to HLA incompatibility.
However, easy extraction procedures and the vast availability of these cells are likely to support the demand for adult stem-cell banking and ensure the growth of this segment, which will thereby drive the growth of the global market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America is the largest revenue contributor to the global market due to the state-of-the-art technological support and the growing presence of established market players that provide stem-cell storage and processing services and use stem-cells for developing treatments for diseases such as cancer.
Moreover, the US and Canada are the highest revenue contributors in the region due to several factors, such as the presence of a well-developed healthcare system, which lets market players providing biotechnology solutions such as stem-cell banking easily establish themselves in the market. Furthermore, personalized medicines through stem-cell therapy have many benefits that are essential for the future of personal health. Hence, such factors will drive the demand for stem-cell banking, thereby driving the regional market during the forecast period.
The market is witnessing significant growth, propelled by the surge in demand for personalized medicines and the increasing focus on regenerative medicines. Stem cell banking offers personalized banking applications with various sources such as placental stem cells, embryonic stem cells, bone marrow stem cells, and adipose tissue stem cells, catering to diverse therapeutic needs. A notable trend in this market is the growing interest in stem cell-based research and its therapeutic potential in treating various medical conditions.
However, amidst this growth, challenges persist, particularly concerning ethical concerns in stem cell research, which necessitate stringent regulatory frameworks and public awareness initiatives. Overcoming these challenges is crucial for ensuring the sample preservation integrity and sustainability of tissue banks and biobanks, ultimately driving market growth analysis and market forecasting in this sector.
The surge in demand for tailored medications is the primary driver of market expansion. Personalized medicines cater to patients' unique characteristics, needs, and preferences. Consequently, research institutions are actively exploring avenues to create customized therapies, focusing on utilizing mesenchymal stem cells due to their numerous advantages. These advantages encompass reduced risk of immune rejection, elimination of the necessity for embryonic stem cells, decreased reliance on anti-rejection medications, lower probability of graft rejection, and diminished likelihood of developing graft-versus-host disease (GvHD). Stem cell isolation techniques play a crucial role in this endeavor. Market analysis indicates a promising outlook for growth, with forecasts highlighting the significance of leveraging used and unused stem cells to address neurodegenerative conditions and the implications of delayed parenthood on healthcare needs.
Furthermore, mesenchymal stem cells (MSCs) that are present in the vascular region of the bone marrow serve as the cellular support of the hematopoietic stem cells (HSCs). In addition, the MSC also possesses some immunosuppressive properties that are beneficial for Hematopoietic stem cell transplantation (HSCT) and for the treatment of inflammatory and autoimmune diseases. Thus, the use of MSC during HSCT has improved the engraftment rate of hematopoietic stem-cells by reducing the GvDH. Hence, such factors will drive the growth of the market during the forecast period.
The rising focus on regenerative medicines is the primary trend shaping market growth. Regenerative medicine is evolving as a buzzword in the medical community. Since the human body is capable of self-healing, regenerative therapies have the potential to treat rare diseases effectively. Regenerative medicine is a method to regrow, repair, or replace damaged or diseased cells, organs, or tissues. It contains stem-cell therapy and platelet-rich plasma (PRP) therapy.
In addition, the research around these therapies is increasing every day. They enhance cell-to-cell communication, which is essential for overall cell health. Thus, the rising trend of regenerative therapies will drive the demand for stem-cell banking, thereby driving the growth of the global market during the forecast period.
Ethical concerns in stem cell research is a challenge that affects market growth. Scientists and policymakers encounter ethical issues with stem-cell development. Several issues include the cloning of embryonic stem-cells and the destruction of sources to create cell lines. Issues regarding safety, scientific purity, and consent for the use of human embryonic stem-cell lines for research purposes have always been a major concern. Federal laws and state policies in terms of secondary usage of genetic information are highly irregular, especially in countries such as the US, which has the biggest market for gene therapy in terms of revenue.
Furthermore, proper infrastructure and recommendations should be established for the collection and usage of stem-cells to alleviate the uncertainty that acts as a hindrance to the donation of stem-cells. The lack of stem-cell donations will prevent advances in treatments and adversely impact the need to preserve stem-cells, consequently impeding the growth of the global market report during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Cordlife Group Ltd.: The company offers products which allows a parent to preserve their child's stem-cells present in the umbilical cord blood and used in treating various life-threatening disorders.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing remarkable growth due to public awareness and the therapeutic potential of stem-cells in treating various conditions. With heavy investments by private companies and government support, the market is advancing rapidly, especially in developed nations.
Stem cells sourced from various tissues such as placental stem cells, bone marrow stem cells, and adipose tissue stem-cells hold immense regenerative potential, offering hope for conditions like leukemia, diabetes, and neurodegenerative disorders. Cryopreservation techniques ensure the viability and accessibility of these cells for future use.
The umbilical cord blood banking sector plays a crucial role in sample preservation and storage, employing advanced transportation technologies for safe sample collection and transportation. Both private stem cell banks and public stem cell banks contribute to sample analysis for research applications and clinical trials.
Regulatory frameworks govern the licensing approval process, ensuring the safety and efficacy of stem cell therapies. As the aging population grows, stem-cell banking addresses the rising prevalence of chronic diseases such as osteoarthritis and cardiovascular diseases. The future of the market looks promising, driven by ongoing medical advancements and market growth and forecasting.
Market Scope |
|
Report Coverage |
Details |
Page number |
156 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.65% |
Market growth 2024-2028 |
USD 8.23 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
9.95 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AMS Biotechnology Europe Ltd., CellSave Arabia FZ LLC, Cordlife Group Ltd., CordVida, Cryo Cell International Inc., Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FUJIFILM Corp., Global Cord Blood Corp., Kids Clinic India Pvt. Ltd., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., New England Cord Blood Bank Inc., PerkinElmer Inc., Plus Therapeutics Inc., ReeLabs Pvt. Ltd., Regenerative Medical Services Pvt. Ltd., Smart Cells International Ltd., StemCyte India Therapeutics Pvt. Ltd., and Vita 34 International AG |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.